213 related articles for article (PubMed ID: 6182782)
41. [Immunofluorescent appearance of antinuclear antibodies and LE cells in connective tissue diseases].
Kolarzowska B
Pol Tyg Lek; 1970 Jan; 25(1):9-12. PubMed ID: 4189987
[No Abstract] [Full Text] [Related]
42. [Routine immunofluorescence studies for demonstration of antinuclear factors].
Hiemann D
Z Gesamte Inn Med; 1969 May; 24(10):150-1. PubMed ID: 4185287
[No Abstract] [Full Text] [Related]
43. Tissue specificity of antinuclear antibodies in scleroderma.
Błaszczyk M; Beutner EH; Rogoziński T; Rzesa G; Jarzabek-Chorzelska M; Jabłońska S; Chorzelski TP
Arch Immunol Ther Exp (Warsz); 1978; 26(1-6):761-4. PubMed ID: 107922
[TBL] [Abstract][Full Text] [Related]
44. [Anti-DNA antibodies in systemic lupus erythematosus. Study of 2 methods of detection].
Sepúlveda C; Rivero S; Jacobelli S
Rev Med Chil; 1985 Feb; 113(2):89-93. PubMed ID: 3909284
[No Abstract] [Full Text] [Related]
45. [Detection of antinuclear factors in rheumatic diseases].
Ménard HA; Myhal D; Camerlain M; Lussier A
Union Med Can; 1974 Apr; 103(4):722-6. PubMed ID: 4601283
[No Abstract] [Full Text] [Related]
46. [Interactions between rheumatoid factors and antinuclear autoantibodies: their occurrence in a concealed state in rheumatoid disease (arthritis); effect of D-penicillamine].
Mach PS; Delbarre F; Piatier D
C R Seances Acad Sci D; 1980 Feb; 290(8):575-8. PubMed ID: 6767559
[TBL] [Abstract][Full Text] [Related]
47. Systemic lupus erythematosus and the crithidia luciliae immunofluorescent test. A comparative study with an adapted Farr radioimmunoassay.
Whitehouse IJ; Fehr K; Wagenhäuser FJ
Z Rheumatol; 1983; 42(1):28-35. PubMed ID: 6342296
[TBL] [Abstract][Full Text] [Related]
48. Fate of human IgG from lupus erythematosus antinuclear antibody positive sera passively transfered to mice.
Herrera-Esparza R; Guzman-Enriquez L; Avalos-Diaz E
Rev Rhum Engl Ed; 1996 Feb; 63(2):111-8. PubMed ID: 8689281
[TBL] [Abstract][Full Text] [Related]
49. [Anti-double strand DNA antibodies and antinuclear antibodies in SLE. I. A new method for determination of anti-double strand DNA antibodies: Trypanosoma equiperdum immunofluorescent method (author's transl)].
Xu SZ; Wang HZ; Li HJ
Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 1981 Mar; 3(1):6-9. PubMed ID: 6458398
[No Abstract] [Full Text] [Related]
50. [The clinical significance of detecting the inhibition of topoisomerase I by the sera of patients with systemic scleroderma].
Shcherbakov AB; Remenson EI; Kirsanova ID; Basnak'ian AG; Guseva NG
Ter Arkh; 1992; 64(5):73-5. PubMed ID: 1333647
[TBL] [Abstract][Full Text] [Related]
51. Crithidia luciliae assay for antibodies to native DNA in procainamide-induced lupus erythematosus.
Dixon JA; Mulhern LM; Whiteside TL; Luksick J
J Rheumatol; 1980; 7(4):544-6. PubMed ID: 6999152
[TBL] [Abstract][Full Text] [Related]
52. Symptomatology and diagnosis in connective tissue disease. Antibodies to extractable ribonucleoprotein in 123 patients reacting with cell nuclei in the immunofluorescence test.
Jonsson J
Scand J Rheumatol; 1976; 5(3):177-83. PubMed ID: 790556
[TBL] [Abstract][Full Text] [Related]
53. Cytotoxins in disease. Autocytotoxins in lupus.
Terasaki PI; Mottironi VD; Barnett EV
N Engl J Med; 1970 Oct; 283(14):724-8. PubMed ID: 5311527
[No Abstract] [Full Text] [Related]
54. The relative value of antibody assays in the differential diagnosis of systemic lupus erythematosus and rheumatoid arthritis with special emphasis to ultramicro ELISA for anti-ds DNA.
Wollina U
Dermatol Monatsschr; 1984; 170(10):645-7. PubMed ID: 6391968
[No Abstract] [Full Text] [Related]
55. [The characterization and application of antibodies against nucleic acids].
Kitagawa Y; Okuhara E
Tanpakushitsu Kakusan Koso; 1984 Apr; 29(4):266-81. PubMed ID: 6205418
[No Abstract] [Full Text] [Related]
56. Comparison of substrates for the detection of antinuclear antibodies in normals and in patients with connective tissue and other diseases.
Lipscomb MF; Cope LD; Stephens GL; Deng JS; Gilliam JN
Diagn Immunol; 1984; 2(3):181-7. PubMed ID: 6388982
[TBL] [Abstract][Full Text] [Related]
57. The comet pattern of nuclear immunofluorescence.
Johnson GD; Smith ME; Holborow EJ
Clin Exp Immunol; 1972 Mar; 10(3):463-8. PubMed ID: 4113676
[TBL] [Abstract][Full Text] [Related]
58. Antinuclear antibodies in Thai patients with connective tissue diseases.
Panicheewa S; Verasertniyom O; Chitrabamrung S; Vanichapuntu M; Vatanasuk M
Asian Pac J Allergy Immunol; 1987 Jun; 5(1):47-52. PubMed ID: 3304322
[TBL] [Abstract][Full Text] [Related]
59. [Clinical usefulness of detection of serum antinuclear antibodies by the immunofluorescence method].
Wranicz A
Przegl Dermatol; 1971; 58(6):685-90. PubMed ID: 4945137
[No Abstract] [Full Text] [Related]
60. Letter: Antinuclear antibodies-clinical significance of the nuclear immunofluorescent patterns.
Burnham TK; Bank PW
Am J Clin Pathol; 1975 Aug; 64(2):289-90. PubMed ID: 1098444
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
